DLP Versus SLM Stackable Surgical Guide
Launched by SUEZ CANAL UNIVERSITY · Nov 7, 2022
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Preoperative evaluation:
intra-oral and extra-oral examination and medical history for each patient will be recorded to assure that the patient will be eligible for the research.
Written informed consent will be assigned by the patients who will be included in the study.
Preoperative records Polyvinyl siloxane (PVS) impressions for both arches will be made. Also, an interocclusal record will be recorded.
The poured upper and lower cast will be mounted on the articulator and will be scanned using a tabletop scanner (DOF swing, DOF, Korea). the scanned file will be saved in stl format Cli...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • well healthy patients
- • patients with maxillary terminal dentition
- Exclusion Criteria:
- • Patients with, systemic disease that might complicate post-operative healing or contribute to bone resorption
- • patients with parafunctional habits, poor oral hygiene, limited mouth opening, severe alveolar bone deficiencies,
- • patients with uncontrolled diabetes, current irradiation to the head or neck, psychological disorders, or alcohol, tobacco, or drug abuse
About Suez Canal University
Suez Canal University is a distinguished academic institution dedicated to advancing medical research and education in the region. As a clinical trial sponsor, the university focuses on conducting innovative studies that aim to enhance patient care and outcomes. Leveraging its strong network of healthcare professionals and state-of-the-art facilities, Suez Canal University fosters collaboration between researchers and clinicians to explore new therapeutic approaches and validate clinical practices. Committed to ethical standards and scientific rigor, the university plays a pivotal role in contributing to the global body of medical knowledge and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ismailia, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials